Red Arrow Therapeutics has closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan: Beyond Next Ventures, The University of Tokyo Edge Capital Partners, Keio Innovation Initiative, and OSAKA University Venture Capital.

Red Arrow Therapeutics is a biotech startup founded in 2021 and headquartered in US, developing an innovative drug delivery system with nanotechnology.